Inventor · disambiguated record
Betty Y. Chang
Also filed as: CHANG BETTY · CHANG BETTY Y · CHANG BETTY YU-CHING
6 granted patents·17 pending applications·35 citations·filing 2002–2020
80Inventor score
Files withPHARMACYCLICS LLC14PHARMACYCLICS INC3ALDERBIO HOLDINGS LLC2ALDERBIO HOLDING LLC1BUGGY JOSEPH J1
Top patents by PatentIndex Score
23 records- 0191US9717731B2TEC family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2013·Granted Aug 1, 2017·14 cites·6 claims
- 0290US9730938B2Bruton's tyrosine kinase inhibitor combinations and uses thereofPHARMACYCLICS LLC·Filed 2015·Granted Aug 15, 2017·16 cites·23 claims
- 0377US9884909B2Anti-NGF compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2013·Granted Feb 6, 2018·1 cites·15 claims
- 0475US10954567B2Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK)PHARMACYCLICS LLC·Filed 2013·Granted Mar 23, 2021·2 cites·23 claims
- 0574US9783602B2Anti-NGF compositions and use thereofDUTZAR BENJAMIN H·Filed 2011·Granted Oct 10, 2017·2 cites·17 claims
- 0669US2020062837A1Anti-ngf compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2019·Application pending·0 cites
- 0762US2020147084A1Tec family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 0859US2014371241A1Tec family kinase inhibitor adjuvant therapyPHARMACYCLICS INC·Filed 2014·Application pending·0 cites
- 0958US10344083B2Anti-NGF compositions and use thereofALDERBIO HOLDING LLC·Filed 2016·Granted Jul 9, 2019·0 cites·14 claims
- 1057US2020368235A1Ibrutinib combination therapyPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 1155US2018071293A1Tec family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 1255US2020397895A1Treatment using bruton's tyrosine kinase inhibitors and immunotherapyPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 1354US2020030330A1Bruton's tyrosine kinase inhibitor combinations and uses thereofPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 1451US2017027941A1Bruton's Tyrosine Kinase Inhibitor Combinations and Uses ThereofPHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 1550US2018071295A1Bruton's tyrosine kinase inhibitor combinations and uses thereofPHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 1650US2015118222A1Treatment using bruton's tyrosine kinase inhibitors and immunotherapyPHARMACYCLICS INC·Filed 2014·Application pending·0 cites
- 1747US2004071659A1Viral-mediated delivery and in vivo expression of polynucleotides encoding anti-angiogenic proteinsFiled 2002·Application pending·0 cites
- 1846US2013178483A1Methods and Compositions for Inhibition of Bone ResorptionBUGGY JOSEPH J·Filed 2012·Application pending·0 cites
- 1946US2016287592A1Ibrutinib combination therapyPHARMACYCLICS LLC·Filed 2014·Application pending·0 cites
- 2041US2015260723A1Companion diagnostics for tec family kinase inhibitor therapyPHARMACYCLICS INC·Filed 2013·Application pending·0 cites
- 2136US2016032404A1Biomarkers for predicting response of dlbcl to treatment with a btk inhibitorPHARMACYCLICS LLC·Filed 2015·Application pending·0 cites
- 2234US2017354655A1Tlr inhibitor and bruton's tyrosine kinase inhibitor combinationsPHARMACYCLICS LLC·Filed 2015·Application pending·0 cites
- 2326US2016022684A1Bet inhibitor and bruton's tyrosine kinase inhibitor combinationsPHARMACYCLICS LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Betty Y. Chang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →